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ABSTRACT OF THESIS 
 
 
INCREASE OF BASAL OXIDATIVE STRESS LEVELS AND IMPAIRMENT OF HEME 
OXYGENASE-1/BILIVERDIN REDUCTASE POST-TRANSLATIONAL MODIFICATION 
BY THE DEFECT OF PARKINSON-RELATED GENE OF PINK1 
 
Parkinson disease (PD) is the most common movement disorder and the 
second most common neurodegenerative disease. PINK1, PTEN-induced kinase 
1, functions as a serine/threonine kinase as well as a protector of mitochondrial 
function. Mutations in PINK1 gene result in either mitochondria dysfunction or 
disruption of kinase signaling pathways involved in the pathogenesis of PD.  
In this thesis, oxidative stress levels were examined in the brain of PINK1 
knockout mice, and also how heme oxygenase-1 and biliverdin reductase are 
affected in brain of PINK1 knockout mice. In addition, posttranslational 
modifications are a way to control the behavior of proteins, so posttranslational 
modifications of the brain of PINK1 knockout mice, including both oxidative 
modification and phosphorylative modification, were examined. 
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Chapter 1. Introduction 
 
 The studies presented in this thesis gained insight into the role of oxidative 
stress, levels of heme oxygenase-1/biliverdin reductase (HO-1/BVR) along with 
post-translational modifications of BVR in the brain of PINK1 knockout mice to 
explore possible pathogenic mechanisms of Parkinson Disease (PD). Currently, 
there are about 6.3 million people worldwide suffered from PD, and this number 
will increase to 8.7 to 9.3 million by 2030 according to the report from European 
Parkinson’s Disease Association. Therefore, the study of PD associated gene, 
PINK1, would be meaningful. 
 As we known, oxidative stress is an imbalance between the levels of 
antioxidants and oxidants which contributes to the pathogenesis of 
neurodegenerative diseases (Butterfield and Kanski 2001). Normally, antioxidant 
system helps to neutralize oxidative insults. However, it could be not sufficient to 
compensate the excess amount of oxidative stress when homeostasis in cells is 
disrupted. Oxidative damage can be quantified by protein carbonylation, lipid 
peroxidation, and protein nitration (Dalle-Donne, Rossi et al. 2003, Dalle-Donne, 
Rossi et al. 2006). PINK1 is a serine/threonine protein kinase served as a 
protector of mitochondria. Dysfunction of PINK1 protein disrupts mitochondrial 
function and results in the formation of oxidative stress (Gautier, Kitada et al. 
2008). The HO-1/BVR system plays a key role in the response to cell stress. 
Heme oxygenase-1 (HO-1) is an enzyme that converts heme b to biliverdin. 
Biliverdin subsequently is converted to bilirubin by biliverdin reductase (BVR). 
Bilirubin is considered as a strong antioxidant protecting cells from oxidative 
damage (Barone, Di Domenico et al. 2014).  
In addition, oxidative translational modification of a specific protein shows 
how it responds to oxidative stress, while phosphorylation translational 
modification regulates the activity of this protein. This thesis also provides 
evidence that the potential antioxidant characteristic of BVR keeps oxidative 
modification of BVR back to normal level. On the other hand, increases of BVR 
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phosphoserine and phosphothreonine in the brain of PINK1 knockout mice 
conceivably is a compensatory response to the elevated oxidative stress, 
potentially activating the reductase function of BVR. Analysis of the PINK1 
knockout brain will provide further understanding of PD. 
 To summarize, this thesis research has used the brain of PINK1 knockout 
mice to achieve the following goals: 
1. To provide an evidence that oxidative stress plays an important role in 
PINK1 deficiency cells. 
2. To verify the efficiency of HO-1/BVR antioxidant system in the cells 
suffered from oxidative stress. 
3. To determine the oxidative/nitrosative stress-induced modification and 
phosphoserine and phosphothreonine of BVR. 
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Chapter 2. Background 
 
2.1 Oxidative Stress  
2.1.1 Overview of Oxidative Stress 
 Oxidative stress (OS) is defined as an imbalance between the level of 
antioxidants and oxidants favoring the latter when physiological homeostasis is 
disrupted. OS has been reported to play a prominent role in the pathogenesis of 
neurodegenerative disorders including Parkinson’s disease (PD) (Jenner, Dexter 
et al. 1992, Jenner 2003). Brain is one of the most vulnerable organs to oxidative 
damage since it has a high consumption of oxygen, high number of mitochondria 
that leak superoxide free radicals, and is rich in polyunsaturated fatty acids 
(PUFAs) that can be attacked by free radicals easily. Moreover, brain 
concentrates metal ions suggesting a strong possibility to contribute to oxidative 
stress in age-related neurodegenerative diseases (Bush 2000). Excess iron 
levels in the substantia nigra in PD leads to enhanced production of free radicals 
and eventually cause oxidative events (Hirsch, Brandel et al. 1991). Low level of 
antioxidants in brain is another reason to cause oxidative damage in brain. In PD, 
reduced glutathione (GSH) levels are decreased while oxidants make more 
negative effects on brain (Sofic, Lange et al. 1992). 
 Within cells oxidative damage to proteins, lipids and DNA is caused by the 
excess production of oxidants even though they serve as second messengers 
and activators of signaling cascades with a basal level (Suzuki, Forman et al. 
1997, Goldstein, Mahadev et al. 2005). Oxidants can be either free radical or 
non-radical molecules and either reactive oxygen species (ROS) or reactive 
nitrogen species (RNS). In general, the majority of ROS/RNS are derived from 
superoxide anions (O2.-), which are the products of O2 and electron by 
transferring electron leaked from the ETC to ground state O2 (reaction 1) 
(Turrens 2003). However, ROS/RNS also come from other sources, such as 
environmental toxins, ultraviolet light, and cellular processes (Mena, Ortega et al. 
2009). 
4 
 
          O2 + e-                        O2.-                                                  (reaction 1)  
 Furthermore, O2.- readily reacts with other reactive species when 
antioxidants are deficient to produce more detrimental ROS/RNS, such as 
hydroxyl (OH.), hydrogen peroxide (H2O2), hypochlorous acid (HOCl) and 
nitrogen dioxide (NO2.). Some of superoxide anions can be dismutated to 
hydrogen peroxide (H2O2) by superoxide dismutase (SOD) (reaction 2). 
Subsequently, newly formed H2O2 will react with excess superoxide anion 
(reaction 3). It is noteworthy to indicate that the partially reduced product, OH., is 
the most reactive and unstable form of ROS which can also be generated by the 
other two pathways (Turrens 2003). One of which is via Fenton reaction using 
reduced metal ions, such as iron and copper, released by some metal-binding 
proteins. (reaction 4-5) (Berlett and Stadtman 1997, Barnham, Masters et al. 
2004).  
         O2.-               SOD           H2O2 + H2O                (reaction 2) 
 2H2O2 + 2O2.-                         OH- + O2 + OH.           (reaction 3) 
    H2O2 + Fe2+                          OH- + Fe3+ + OH.        (reaction 4) 
   H2O2 + Cu+                           OH- + Cu2+ + OH.        (reaction 5) 
 The third pathway of OH. formation is through the presence of nitric oxide 
(NO.) and the hemolysis of ONOOH. The product of reaction 6, peroxynitrite 
(ONOO-), is another strong oxidant. This is also a pathway to generate some 
prominent RNS (reaction 6-8) (Radi 2004, Goldstein, Lind et al. 2005). A more 
detailed mechanism for reaction of NO. with O2.- is shown in section 2.1.4. 
     NO. + O2.-                        ONOO-                          (reaction 6) 
     ONOO-  + H+                         ONOOH                  (reaction 7) 
     ONOOH                         NO2. + OH.                     (reaction 8) 
 OH., as a secondary oxidizing species, is quite damaging. It is able to 
interact with almost any other free radical or nonradical species to cause post 
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translational modifications (PTM) such as protein oxidation, lipid peroxidation. At 
the same time, the other product, NO2., is involved in protein nitration. Thereby, 
oxidative damage has been amplified. In addition, when NO. is consumed to form 
ONOO-, NO. is depleted. However, NO. is important to many physiological 
processes including, among others, vasodilation and neurotransmission (Belvisi, 
Stretton et al. 1992, Steinberg, Brechtel et al. 1994). As we can see, cells 
undergo oxidative stress even if slight overabundance of ROS/RNS. The results 
of oxidative damage usually cause protein structural alteration, enzyme inhibition, 
and the impairment of regulatory functions.  
 
2.1.2 Protein carbonylation  
The presence of protein carbonyl groups in brain proteins is one of the 
most common features in neurodegenerative disease. Because protein carbonyl 
groups form in early stages of these disorders and are relative stable, these are 
commonly used as an index of oxidative stress. There are five pathways to 
generate protein carbonyl groups. Carbonyl derivatives are firstly yielded by 
oxidation of the side-chains of several amino acids especially for proline, arginine, 
lysine, and threonine residues (Table 2.1) (Dalle-Donne, Rossi et al. 2003). 
Cleavage of the peptide bond by either diamide or α-amidation pathways is the 
second way to form CO double bonds (Figure 2.1) (Berlett and Stadtman 1997, 
Stadtman and Levine 2003). Protein carbonyl groups can be generated through 
oxidation of glutamyl side chains (Figure 2.2) (Berlett and Stadtman 1997, 
Stadtman and Levine 2003). Protein carbonyls can also react for processes of 
glycoxidation (Stadtman and Levine 2003).  Lastly, protein carbonyl groups result 
from protein addition by a product of lipid peroxidation, HNE, (discussed later). 
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Table 2.1 Carbonyl groups modified amino acids 
Amino acid Carbonyl derivatives Structure 
Proline 2-Pyrrolidone 
 
Arginine Glutamic semialdehyde 
 
Lysine Aminoadipic semialdehyde 
 
Threonine 2-amino-3-keto butyric acid 
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Figure 2.1 Cleavage of the peptide bond by diamide or α-amidation 
 
 
 
Figure 2.2 Oxidation of glutamyl residues to form protein carbonyl groups 
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As an oxidative damage, protein carboxylation disrupts tertiary structure of 
protein leading to unfolding or conformational changes. The amino acid on 
protein become more polar with the introduction of protein carbonyl groups, 
thereby exposing hydrophobic residues to the aqueous environment and losing 
functions (Dalle-Donne, Aldini et al. 2006). Increased protein carboxylation, 
coupled with less efficiency of proteolysis may result in the aggregates of 
misfolded proteins associated diseases including PD. Protein carbonyl levels can 
be quantified by immunohischemistry after being derivatized with 2,4-
dinitrophenylhydrazine (DNPH) to form the protein hydrazone (Dalle-Donne, 
Rossi et al. 2003).  
 
2.1.3  Lipid peroxidation 
 Lipids are the most common components of biological membrane. Lipids 
play an important role in fluidity, flexibility, and selective permeability. Even small 
changes of lipid may greatly alter the physiological properties of the membrane, 
contributing to the pathology of diseases. Lipid peroxidation is one of the 
outcomes of oxidative stress and is a source to spread and amplify free radical 
reaction (Gutteridge 1995). Among all kinds of lipids, phospholipid is the most 
susceptible one to undergo this process not only because of high level of 
polyunsaturated fatty acids (PUFAs) but also because of a relative easier 
accessibility to free radicals. Generally, lipid peroxidation consists of three stages: 
initiation, propagation, and termination. In the initiation stage, allylic hydrogen on 
acyl chains of phospholipids is easily abstracted by free radicals such as OH., 
RO., ROO. to form a carbon center lipid radical (L.). The lipid radical 
subsequently reacts with oxygen, producing a lipid peroxyl radical (LOO.). This 
radical is able to abstract another allylic hydrogen from a different PUFA to 
produce a lipid hydroperoxide (LOOH) and a new lipid radical (L.), which 
continuously reacts with oxygen molecular. This process is a chain reaction 
called propagation. As a result, more and more LOOH are formed. In the 
presence of reduced metal ions, LOOH can be reduced to phospholipid alkoxyl 
radical (LO.), and then break down to reactive aldehyde products. When the 
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concentration of lipid radical is high enough, the chain reaction stops by collision 
of two radicals (reactions 9-12) (Catala 2006, Catala 2009). This complex 
process modifies physical properties of membrane function including change in 
membrane fluidity, membrane permeability, and membrane protein activity.  
  LH + X.                          L. + XH                                   (reaction 9) 
  L. + O2                          LOO.                                       (reaction 10) 
  LOO. + LH                         LOOH + L.                         (reaction 11) 
  LOO. + LOO.                         Non-radical + O2            (reaction 12)                  
 4-Hydroxynonenal (HNE), a major aldehyde product of lipid peroxidation, 
has been recognized as an indicator of lipid peroxidation. HNE is involved in 
apoptosis, damage of proteasomal function, and the alteration of signal 
transduction, contributing to neurodegenerative diseases (Kruman, BruceKeller 
et al. 1997, Ferrington and Kapphahn 2004). The γ carbon of aldehyde group is 
electron deficient so that be able to react with nucleophilic groups such as 
sulfhydryl groups, imidazole groups, and amino groups. Therefore, HNE reacts 
with cysteine, histidine, and lysine by Michael addition to produce reactive 
aldehyde derivatives (Table 2.2) (Esterbauer, Schaur et al. 1991). This is another 
way to generate protein carbohydrate derivatives. Protein polarities and 
structures are altered because of the products of lipid peroxidation. As a 
consequence, this whole process alters lipid-lipid and lipid-protein interactions as 
well as membrane functions.  
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Table 2.2 HNE adduct of Histidine, Lysine, and Cysteine 
Amino Acid HNE Protein–alkenal Adducts 
Histidine 
 
 
 
Lysine 
 
 
Cysteine 
 
 
 
 
 
2.1.4  Protein nitration  
Similar to ROS, protein nitration caused by toxic RNS leads to oxidative 
damage to proteins as well. Nitric oxide (NO.) is regarded as an initial source of 
this process, which is able to produce other relative reactive intermediates. 
Normally, NO. is involved in cell signaling, vasodilation, and immune response 
(Drew and Leeuwenburgh 2002). However, excess nitric oxide can participate as 
a cytotoxin in cellular. NO. is formed by nitric oxide synthase (NOS) family. NOS 
catalyzes the conversion of L-arginine to L-citrulline and forms NO. as a 
byproduct (Figure 2.3). The NOS family insists of three distinct isoforms: Ca2+-
11 
 
dependent neuronal NOS (nNOS), Ca2+-dependent endothelial NOS (eNOS), 
and Ca2+-independent inducible NOS (iNOS), which play different roles in 
different organs (Alderton, Cooper et al. 2001, Drew and Leeuwenburgh 2002).  
 
Figure 2.3   Formation of nitric oxide (NO.) by nitric oxide synthase (NOS) 
 
Mostly, nitric oxide mediates protein nitration on two aspects. It also 
triggers S-nitrosylation of reduced cysteine residues. Oxygen that is required in 
the S-nitrosylation is converted to superoxide (Gow, Buerk et al. 1997, 
Broniowska and Hogg 2012). Most of superoxide in vivo is dismutated by SOD. 
However, the reaction of HO-O. with NO. has a larger rate constant than with 
SOD. Therefore, NO. competes SOD for HO-O. to form peroxynitrite and nitrogen 
dioxide (reaction 13-16) (Radi 2004).  
Protein-SH + NO.                   Protein-S-N.-OH                       (reaction 13) 
Protein-S-N.-OH + O2                 Protein-S-NO + HO-O.         (reaction 14) 
HO-O.               SOD               H2O2 + O2                                     (reaction 15) 
HO-O. + NO.                  ONOOH                   NO2. + OH.          (reaction 16) 
 
The most pronounced modification caused by nitric oxide is the formation 
of 3-nitrotyrosine (3-NT). Nitric oxide is first converted to a very reactive oxidant 
peroxynitrite anion (ONOO-). The latter has been observed to react with CO2 to 
form ONOOCOO-, which subsequently breaks down into nitrogen dioxide (NO2.) 
and carbonate radical (CO3.-) (reaction 17-18). With the presence of CO3.-, tyrosyl 
radical is generated by losing an electron from tyrosine. Ultimately, NO2. attaches 
to tyrosyl radical to yield 3-NT (Figure 2.4). This is a radical-radical reaction, 
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peroxynitrite itself cannot react with tyrosine directly. Site specific nitration of 
tyrosine causes steric restriction so that changes the function of protein by 
lowering pKa of hydroxyl group and providing steric hindrance, thereby inhibiting 
tyrosine phosphorylation (Gow, Duran et al. 1996, Di Stasi, Mallozzi et al. 1999, 
Radi 2004). Nitrated mitochondrial proteins contribute to oxidative damage. 
Therefore, it is important to measure 3-NT level as an index to evaluate protein 
nitration. 
NO. + O2.-                        ONOO-                                             (reaction 17) 
ONOO- + CO2              ONOOCOO-                 NO2. + CO3.    (reaction 18) 
 
 
Figure 2.4 Formation of 3-nitrotyrosine (3-NT) 
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2.2   Parkinson Disease 
2.2.1 Parkinson Disease Overview 
PD is the second most common neurodegenerative disease after 
Alzheimer disease and the most common movement disorder (Giasson, Duda et 
al. 2002, Maragakis and Rothstein 2006).  PD is characterized by progressive 
loss of dopaminergic neurons in the substantia nigra. The clinical symptoms of 
PD include muscle rigidity, tremor, a slowing of physical movement 
(bradykinesia), even a loss of physical movement (akinesia) (Fahn 2003, 
Thomas and Beal 2007). PD usually affects people over the age of 50 with a 
current estimation of 1.5 million in the United States. PD can be either sporadic 
or familial. Although most cases of PD are the sporadic form, studies of genes 
linked to rare familial disease help people better understand the mechanism of 
PD and provide the targets for therapeutic intervention.  
Several genes, including α-synuclein, parkin, DJ-1, UCHL-1, PINK1 and 
LRRK2, have been clearly identified to be associated with PD in both sporadic 
and familial forms. All these five genes play prominent roles in protecting neurons 
from mitochondrial dysfunction, oxidative damage, abnormal protein 
accumulation and protein phosphorylation (Thomas and Beal 2007). α-synuclein 
is a presynaptic protein to play an important role in neurotransmission (Yavich, 
Tanila et al. 2004). Mutations or oxidation of α-synuclein enhance α-synuclein 
aggregation. The abnormal protein aggregation, termed Lewy bodies (LBs), is 
the most typical hallmark of PD brain (Spillantini, Crowther et al. 1998). Parkin 
functions as an E3 ubiquitin protein ligase catalyzing transfer of ubiquitin to 
cellular proteins for subsequent proteolysis and protecting dopamine neurons 
(Walden and Martinez-Torres 2012). DJ-1, known as an antioxidant, is able to 
serve as a scavenger of reactive oxygen species (ROS) and an activator of 
glutamyl cysteine ligase. Moreover, α-synuclein aggregation and subsequent 
death can be blocked by DJ-1 (Shendelman, Jonason et al. 2004, Zhou and 
Freed 2005). UCHL-1 plays an important role in the ubiquitin proteasome 
pathway. It helps to hydrolyze peptide ubiquitin bonds and generate ubiquitin 
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monomers for re-use. The I93M mutation of UCHL-1 was first discovered to 
cause PD, whereas S18Y may reduce risk for PD by inhibiting ligase activity 
(Healy, Abou-Sleiman et al. 2004). Both PINK1 and LRRK2 are mitochondrial 
serine/threonine protein kinases, protecting mitochondrial function. The 
mitochondrion, a critical target in PD, is impaired by mutations of any of above 
genes, which might cause dysfunction in maintenance and survival of 
dopaminergic neurons (Beal 2007).  
Disrupted mitochondrial function is likely to decrease oxidative 
phosphorylation and decrease complex I activity in PD, resulting in ROS 
formation, oxidative stress, and loss of ATP production. Increased oxidative 
stress can induce overload function of the ubiquitin proteasomal system (UPS), 
ultimately leading to irreversible cellular damage and death. In parallel, loss of 
the mitochondrial membrane potential occurs. This leads to opening of the 
mitochondrial permeability transition pore (mPTP), releasing of cytochrome c, 
and activation of mitochondrial-dependent apoptosis (Abeliovich 2007). Growing 
evidence shows that mitochondrial deficiency and oxidative stress play prominent 
roles in PD pathogenesis.  
 
2.2.2  PINK1 Involvement in PD  
 PINK1 (PARK6), PTEN-induced kinase 1, was identified in 2004 as the 
second most genetic cause of recessively inherited early-onset parkinsonism 
(Gandhi, Muqit et al. 2006, Ibanez, Lesage et al. 2006). PINK1 functions as a 
serine/threonine kinase as well as a protector of mitochondrial function. The C-
terminal domain of PINK1 mediates kinase function while the N-terminal 
mitochondrial targeting motif helps to maintain mitochondrial function and 
morphology. PINK1 is localized in the mitochondria membrane, can be found 
throughout the body, and has a function in the whole brain not only in the 
substantia nigra (Gandhi, Muqit et al. 2006). In brief, PINK1 protects neurons in 
four pathways. Firstly, PINK1 phosphorylates TRAP1. Phosphorylated TRAP1 in 
turn blocks generation of mitochondrial ROS and prevents release of cytochrome 
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c from the mitochondrial intermembrane space into the cytoplasm (Plun-Favreau 
and Hardy 2008). Secondly, PINK1 enhances phosphorylation of the 
mitochondrial protease HtrA2. Activated HtrA2 then increases protease activity 
and enhances resistance of cells to mitochondrial stress. Both these pathways 
demonstrate a role for the kinase in maintenance of mitochondrial function and 
prevention of stress-induced apoptosis. Thirdly, PINK1 is also able to interact 
with Parkin and protect the mitochondria by either PI3-kinase/Akt pathway or 
IKK/NF-κB signaling pathway. Parkin acts downstream of PINK1 indicating that 
two genes might share a conserved genetic pathway. Overexpression of Parkin 
can protect against the effect of PINK1 mutation. Lastly, PINK1 enhances the 
activity of anti-apoptotic protein Bcl-2 to reduce apoptosis (Abeliovich 2007, Plun-
Favreau, Klupsch et al. 2007, Mills, Sim et al. 2008). Mutations in PINK1 gene 
result in either mitochondria dysfunction or disruption of kinase signaling 
pathways involved in the pathogenesis of PD. PINK1-deficient cells trigger 
intrinsic mitochondrial apoptosis as stated in the last section. Mutations of PINK1 
also alter mitochondrial integrity and proliferation. Proliferation of mitochondria 
may occur to compensate for dysfunctional mitochondria induced by oxidative 
stress to produce more ATP needed for cell survival. However increased 
numbers of mitochondria will in turn cause extra ROS, which means more 
oxidative damage to cells (Wood-Kaczmar, Gandhi et al. 2008). In the current 
thesis research, PINK1 knockout mice were used as a model to investigate PD.  
 
2.3 Heme oxygenase 
 Heme oxygenase (HO) is an enzyme responsible for degradation of heme 
b to biliverdin, ferrous ion, and carbon monoxide (CO) (reaction 19). Heme b 
comes from heme-containing proteins such as hemoglobin, myoglobin, 
cyclooxygenase, etc. Biliverdin is a potential antioxidant which is immediately 
converted to bilirubin by biliverdin reductase. Bilirubin has been known as a 
powerful antioxidant. On the other hand, ferrous ion and CO would be toxic at 
high concentrations. Accumulation of ferrous ion would lead to Fenton chemistry 
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as mentioned in Section 2.1.1, even though some of ferrous ion can be 
sequestered by ferritin. Therefore, excess of ferrous ion and CO may contribute 
the pathology of Parkinson disease. Generally, heme oxygenase has two 
isoforms: Heme oxygenase-1 (HO-1) and Heme oxygenase-2 (HO-2). HO-1 is an 
inducible isoform that is upregulated by transcription factors in response to 
inducers. Stress inducers can be numerous, such as oxidants, heavy metals, 
hormones, etc. HO-2 is a constitutive isoform that is usually expressed at a low 
level under physiological conditions. In addition, HO-1 has been observed to be 
beneficial for learning ability (Chen, Huang et al. 2013). 
 
(reaction 19)  
 
2.4 Biliverdin reductase  
2.4.1 Biliverdin reductase Regulation, and Reductase Activity 
As mentioned above, biliverdin reductase (BVR) firstly was recognized as 
a reductase that converts biliverdin to bilirubin (reaction 20). NADPH participates 
this reaction under basic pH, whereas NADH is used under acidic conditions. 
Bilirubin is the final product from heme degradation which is an antioxidant 
capable of ROS scavenge. As a response to the increase level of heme 
degradation and HO-1 expression, the conversion of biliverdin to bilirubin would 
increase subsequently. However, organisms are able to balance these changes. 
Extra bilirubin inhibits BVR activity to accumulate biliverdin. The negative 
feedback inhibits HO-1 activity, leading HO-1/BVR system to return to normal 
(Kutty and Maines 1981, Kutty and Maines 1984). 
                                                                                                        (reaction 20) 
 
17 
 
2.4.2 Biliverdin reductase kinase activity, and the role in cell signaling 
 Biliverdin reductase recently has been also identified as one of a rare 
group of dual-specificity kinases that has the ability to autophosphorylate, or 
phosphorylate serine/threonine and tyrosine residues (Hunter and Cooper 1985). 
Different mammalian species share more than eighty percent of BVR gene 
sequence (Maines 2005). Traditionally, the sequence consists of catalytic domain 
and regulatory domain. In the recent years, human biliverdin reductase (hBVR) 
has been studied extensively. BVR is identified to have potential functions in the 
insulin signaling pathway. Insulin signaling pathway starts with insulin receptor 
(IR) which is a protein tyrosine kinase consisting of α-subunit and β-subunit 
connected by disulfide bonds. The α subunit has a binding site to insulin or 
insulin growth factor 1 (IGF-1). Insulin/IGF-1 attaches to the α-subunit of IR and 
tyrosine phosphorylation of β-subunit activates IR. BVR is activated by 
phosphorylation. In the insulin signaling pathway, BVR is upregulated by insulin 
receptor tyrosine kinase and negatively affects glucose uptake. The subsequent 
phosphorylated BVR effectively competes with insulin receptor kinase for 
serine/threonine phosphorylation of insulin receptor substrate 1 (IRS-1) (Lerner-
Marmarosh, Shen et al. 2005, Maines 2005). Then two major arms of signaling 
pathways are activated: mitogen-activated protein kinase (MAPK) and PI3K 
cascades (Figure 2.5). Except for kinase acitivity, hBVR also functions as a 
transcriptional factor in insulin signaling pathway (Maines 2007).  
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Figure 2.5 Function of BVR as a kinase in the IR/IGF-1 signaling cascade 
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2.5 Hypothesis 
Since oxidative stress contributes to neurodegenerative disease and 
PINK1 knockout mice is a model of Parkinson’s disease, there will be an 
increase level of oxidative stress observed in the brain of PINK1 knockout mice. 
The increased level of oxidative stress is able to induce overexpression of heme 
oxygenase 1 and biliverdin reductase with aid of the transcription factor Nrf2. 
With the enhanced expression of BVR, increased level of biliverdin will result 
which scavenges ROS/RNS. Therefore, the oxidative posttranslational 
modification of BVR can return to normal. Additionally, biliverdin reductase 
phosphoserine and phosphothreonine in the brain of PINK1 knockout mice may 
be increased responding to the elevated oxidative stress. 
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Chapter 3. Materials and Experimental Procedures 
 
3.1 Chemicals and Materials  
 2, 4-Dinitrophenylhydrazine (DNPH), primary Rb x DNP antibody, re-blot 
plus strong antibody stripping solution were purchased from Chemicon 
(Temecula, CA). Protease inhibitors, primary anti-biliverdin reductase and anti-
nitrotyrosine antibodies, secondary anti-rabbit IgG alkaline phosphatase and anti-
tubulin antibodies were purchased from Sigma-Aldrich (St. Louis, MO). Primary 
anti-HNE antibody was purchased from Alpha Diagnostic (San Antonio, TX). 
Primary anti-phosphothreonine, anti-phosphoserine antibodies were obtained 
from Invitrogen (Camarillo, CA). Secondary anti-rabbit IgG horseradish 
peroxidase, cydye3 and cydye5 were purchased from GE healthcare (Pittsburgh, 
PA). BCA protein estimation assay kit, BCIP/NBT color development substrate 
(5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium) were purchased 
from Pierce (Rockford, IL). Polyacrylamide gels, Precision plus proteinTM all blue 
standards, XT MES electrophoresis running buffer, nitrocellulose membranes, 
and ClarityTM western ECL substrate were got from Bio-Rad (Hercules, CA). 
 
3.2 Animals 
In this work, whole brain samples of PINK1 knockout mice (male, n=6) and 
age-matched control mice (male, n=6) were obtained from our collaborator, Dr. 
Hans Büeler, University of Kentucky. All mice were mixed background (C57BL/6 
x 129/Sv). Generation of PINK1 knockout mice was described in a previous 
publication (Akundi, Huang et al. 2011). Knockout and control mice were 
euthanized at six months old. Brain tissues were isolated immediately and stored 
at -80°C until use. 
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3.3 Sample Preparation 
 Brain samples were homogenized using a glass mortar and pestle in 
isolation buffer (pH 7.4, 300-500 µL for each sample) containing 0.32M sucrose, 
2mM EDTA, 2mM EGTA, 20mM HEPES, 0.2mM PMSF, leupeptin (4µg/ml), 
pepstatin (4µg/ml), aprotinin (5µg/ml), and phosphatase inhibitor cocktail (1:100). 
After homogenization, tissues were transferred into a set of Eppendorf tubes. 
Aliquot samples (200 µL) to another Eppendorf tube and each sample was 
sonicated with a Fisher 550 sonic Dismembrator (Fischer Scientific, Pittsburgh, 
PA) for 20s at 20% power. Then another 100 µL of isolation buffer was added. 
Samples were centrifuged 10 min at 3000rpm, 4°C using a Hettich Mikro 22R 
Microcentrifuge (Hettich, Beverly, MA) and all the supernatants were collected for 
one-dimensional SDS-PAGE processing. Supernatants (100 µL) were transferred 
into another set of tubes following the addition of 200 µL of isolation buffer, and 
the tissues were saved for slot blotting. Sample concentrations were determined 
by the Bicinchoninic Acid (BCA) protein estimation assay. All the samples were 
stored at -80°C.  
 
3.4 Bicinchoninic Acid (BCA) Protein Estimation Assay 
 All the protein concentrations in this study were determined using the BCA 
protein estimation assay. This assay couples the reduction of Cu2+ to Cu1+ by 
protein in an alkaline medium with the colorimetric detection of Cu1+ by BCA. The 
BCA assay reagent is the mixture of reagent A (sodium carbonate, sodium 
bicarbonate, bicinchoninic acid and sodium tartrate in 0.1 M sodium hydroxide) 
and reagent B (4% cupric sulfate pentahydrate) in the ratio (49:1) freshly made 
before the experiment. In the former reaction, which known as the Biuret reaction, 
Cu2+ ions from reagent B are reduced by the presence of four amino acids 
(cysteine, cystine, tryptophan and tyrosine) and peptide bonds (reaction 1). The 
resultant Cu1+ ions subsequently react with two BCA molecules from reagent A to 
generate purple colored complexes which exhibit a strong linear absorbance at 
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562 nm (reaction 2). Protein concentration is directly proportional to the intensity 
of absorbance.  
Proteins (peptide bonds & amino acids) + Cu2+                   Cu1+         (reaction 1) 
Cu1+ + 2 Bicinchoninic Acid (BCA)                 BCA-Cu1+ complex (purple-colored)                                                     
(reaction 2) 
Each sample (2 µL) was pipetted along with in duplicate gradient 
concentrations of standards, bovine serum albumin (BSA) into a 96-well 
microplate (Evergreen Scientific, Los Angeles, CA); samples and standards were 
diluted with the BCA assay reagent to make a final volume to 100 µL in each well; 
the microplate was incubated for 15 min at 37 °C and gently rocked before 
reading the absorbance in a μ-Quant UV plate reader (Bio-Tek, Winooski, VT). 
Finally, the protein concentration follows was calculated using the Lambert-Beer 
law. 
 
3.5 Slot Blot Analysis Oxidative Stress 
3.5.1 Slot Blot Technique 
Slot blot, a microfraction of the dot blot technique, is a useful tool for the 
detection of global levels of a protein modification such as protein carbonyl (PC) 
or 3-nitrotyrosine (3-NT) with very small amount of samples required (< 1 µg). 
Protein samples firstly are dissolved in SDS containing buffer, whereas PC later 
needs to be incubated with DNPH before loading in duplicate on the 
nitrocellulose membrane under vacuum. SDS imparts negative charges to 
proteins. Therefore, positively charged nitrocellulose membrane is able to bind 
proteins, but any uncharged materials will pass through the pores of 
nitrocellulose membrane. The membrane is removed from the apparatus 
followed by blocking with BSA and probing with specific primary and secondary 
antibodies corresponding to a specific protein modification. With the colorimetric 
development, spots are visualized and can be quantitated based on the intensity 
using Image Lab software. 
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3.5.1.1 Detection of Protein-Bound Carbonyls 
 Protein carbonyls are a global index of protein oxidation. Carbonyl groups 
of protein except for the primary chain peptide bond carbonyls are derivatized by 
DNPH to form hydrazones (Figure 3.1). The protein-bound 2,4-
dinitrophenylhydrazone can be attached to the primary antibody reorganizing the 
hydrazone adduct. A secondary antibody coupled to alkaline phosphatase is 
attached to the primary antibody, and the amount of primary antibody bound is 
finally detected by BCIP/NBT color development substrate (5-bromo-4-chloro-3-
indolyl-phosphate/nitro blue tetrazolium). 
  
 
Figure 3.1  Derivatization of protein carbonyls by DNPH 
 
Each brain sample (5 µL) was derivatized at room temperature by 
incubation with 5 µL of 12% SDS and 10 µL of 10mM DNPH solution in 2N HCl 
for 20 min. The samples were then neutralized by adding 7.5 µL of neutralization 
buffer. Derivatized samples were diluted with PBS to make a final concentration 
of 1 µg/mL. Diluted samples (250 µL/well) were loaded in duplicate onto a 
nitrocellulose membrane under vacuum pressure. Membrane was then incubated 
in a blocking solution containing 750 mg BSA per 25 mL wash blot (35.2g NaCl, 
1.77g NaH2PO4, 9.61g Na2HPO4, 1.5mL TWEEN, diluted to 4L with DI water) for 
one and a half h to prevent non-specific binding of antibodies. Next the 
membrane was incubated with a 1:100 dilution of rabbit polyclonal anti-DNP 
primary antibody for 2 h. Blot was then rinsed three times, 5 min each in wash 
blot, and subsequently incubated with 1:8000 dilution of anti-rabbit IgG-alkaline 
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phosphatase secondary antibody for exactly 1 h. After another three times, 5, 10, 
10 min, respectively, washes, the membrane was colorimetrically developed and 
dried overnight. The membrane was scanned on the second day using 
ChemiDocTM MP Imaging System (Bio-Rad, Hercules, CA) and the bands were 
quantified using Image Lab software.    
 
3.6 One-Dimensional SDS-PAGE and Western Blotting  
 One-dimensional sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (1D SDS-PAGE) is used to separate proteins based on their size, 
shape and molecular weight. Prior to running the gel, 75 µg of each sample were 
suspended in DI water and 4X SDS-sample buffer (5 µL) composed of 0.5 M Tris 
(pH 6.8), 40% glycerol, 8% SDS, 20% β-mercaptoethanol, and 0.01% 
bromophenol blue to make final volume 25 µL. SDS is able to coat proteins and 
impart negative charges on proteins so that samples can migrate from the 
negatively charged anode to the positively charged cathode under the influence 
of a current. Samples were then denatured in boiling water for 5 min and cooled 
immediately on ice before electrophoresis. Precision Plus Protein TM All Blue 
Standards (5 µL) and the prepared samples were loaded in separate lanes on  
12% Bis-Tris polyacrylamide gel using 1X XT MES as running buffer. The electric 
field was initially set at 80 V for the first 8 min and increased to 120 V until the 
blue line reached the bottom of the gel. Sample proteins were separated through 
gel electrophoresis. The relative migration rate (Mr) depends on the resistance of 
gel. Generally, larger proteins have higher resistance with lower Mr compared to 
smaller proteins, though shape (i.e. cylindrical shaped) proteins migrate slower 
than similar MW proteins of spherical shape. 
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Figure 3.2  1D SDS-PAGE 
  
Western blotting is used to immobilize proteins onto the nitrocellulose 
membranes. The membranes can be easily incubated with antibodies of interests 
to measure specific proteins or post-translational modifications of specific 
proteins. In this study, this technique has been extensively used for the detection 
of HNE-bound protein, protein-resident 3-NT, the expression of HO-1 and BVR, 
and oxidative or phosphorylation post-translational modifications of BVR. 
Through running a semi-dry Transfer Cell System (BioRad, Hercules, CA) at 1.0 
A for 30 min, negatively charged proteins were transferred from the gel to the 
positively charged nitrocellulose membrane. During transfer, the gel sandwich 
was made from two thick filter papers, a nitrocellulose membrane, and the gel 
was submerged in transfer buffer containing Tris-HCl, glycine, and methanol. 
Methanol is present to prevent the gel from swelling. The membrane was then 
incubated in a blocking solution for one and a half hours. Protein levels were 
evaluated via incubating with primary antibodies of interest overnight. After three 
5 min washes, samples were incubated with secondary antibodies for exactly 1 h. 
The membrane was washed three times again, and finally developed using 
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immunofluorescence or chemiluminescent techniques. The intensities of bands 
were quantified by Image Lab analysis software.  
1:1000 dilutions of primary anti-heme oxygenase-1 and anti-biliverdin 
reductase antibodies, 1:5000 dilution of primary anti-HNE polyclonal antibody, 
and 1:2000 dilution of rabbit polyclonal anti-3-NT primary antibody were used to 
measure HO-1, BVR, protein-bound HNE, and protein-resident 3-NT levels, 
respectively. Because immunofluorescence development was adopted, the blots 
were then incubated with Cy5 anti-rabbit secondary antibody for 1 h in dark. For 
loading controls, the blots were probed with primary anti-Tubulin antibody and 
secondary Cy3 anti-mouse antibody.  
 
3.7 Identification of Post-translational Protein Modifications Using 
Immunoprecipitation Approaches  
 Immunoprecipitation (IP) is the technique used in to isolate a particular 
protein from samples and quantify post-translational modifications of this 
particular protein. The first step of IP is to incubate 250 µg of protein with the IP 
buffer (0.05% NP-40, 4 µg/mL leupeptin, 4 µg/mL pepstatin, and 5 µg/mL 
aprotinin in PBS; pH 8) shaking 30 min at 4 °C. In order to prevent non-specific 
binding, samples were pre-cleaned with washed protein A/G-agarose beads (50 
µL per sample) for 1 h at 4 °C. This procedure leas to removal of IgGs in the 
samples. Supernatants were transferred to clean Eppendorf tubes after a 5 min 
centrifugation in a Hettich Mikro 22 R microcentrifuge (Hettich, Beverly, MA) at 
2500 rpm, 4 °C. Samples were incubated overnight with the antibody of interest. 
In this study, anti-biliverdin reductase antibody was used to isolate biliverdin 
reductase. Insoluble antigen-antibody-protein A/G complex was formed by the 
addition of washed protein A/G-agarose beads and incubating for 1 h at 4 °C. 
Subsequently the immunocomplex was centrifuged and the pellet was washed 
five times with IP buffer (500 µL each time). Continuous shaking was used during 
all incubation and washing steps. The pellet was suspended in DI water (20 µL) 
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and 4X SDS-sample buffer (5 µL) followed by denaturation in boiling water for 5 
min and cooled immediately on ice. The supernatants containing a particular 
protein were ready for 1D-PAGE and Western blotting (see sections 3.6).  
As described above, the nitrocellulose membrane was incubated with 
primary anti-3NT and anti-HNE antibodies, respectively, followed by the 
incubation of anti-rabbit IgG alkaline phosphatase secondary antibody to detect 
the levels of specific protein oxidative modifications. Blots were developed with 
BCIP/NBT color development substrate.  
For analysis of phosphoserine and phospohthreonine beads, the 
nitrocellulose membrane was incubated with primary anti-phosphoserine and 
anti-phosphothreonine antibodies, respectively, followed by the incubation of 
secondary anti-rabbit IgG horseradish peroxidase to assess the levels of specific 
protein phosphorylation modifications. Blots were developed by 
chemiluminescence techniques using ClarityTM Western ECL substrate. For 
loading controls, the blots were first stripped by stripping solution. After washing 
to remove the stripping solution, the blots were probed with primary anti-biliverdin 
reductase antibody.  
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① Samples in IP buffer 
② Add antibody to form 
antibody/antigen complexes 
③ Add protein A/G-agarose beads 
④ Wash antigen/antibody/ 
(protein A/G-agarose beads) 
complexes 
⑤ Discard supernatant  
1D gel & WB 
Figure 3.3 Immunoprecipitation procedure 
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3.7.1  Identification of Protein Carbonyl Post-translational Modification 
As for the detection of protein carbonyl modification of specific protein, 
post-electrophoretic derivatization was used. The nitrocellulose membrane got 
from immunoprecipitation and Western blotting was dried completely before 
derivatization. In day 2, the membrane was first incubated in a solution consisting 
of 80% TBS and 20% methanol for 5 min. The solution was changed to 2N HCl 
and incubate for 5 min. The membrane was then incubated with 0.5mM 2,4-
dinitrophenylhydrazine (DNPH) in 2N HCl for exactly 5 min. After three 5 min 
washes with 2N HCl and five 5 min washes with 50% methanol, the membrane 
was then incubated with blocking solution. During all the incubation and washing 
steps, continued shaking was applied at room temperature (Conrad, Talent et al. 
2000). The following steps for membrane development were similar to the 
detection of protein-bound carbonyls (see section 3.5.1.1). 
 
3.8 Image analysis  
All the blots were scanned using a ChemiDocTM MP Imaging System (Bio-
Rad, Hercules, CA) and quantified using Image Lab software. In order to prevent 
slight difference in loading, bands intensities were normalized by the intensities 
of loading control. 
 
3.9 Statistical analysis 
 A Student’s t-test was used to compare the levels of oxidative stress, 
expression of HO-1 and BVR, oxidative post-translational modifications of BVR, 
and phosphorylation post-translational modifications of BVR in PINK1 knockout 
mice and wild-type mice. P-values less than 0.05 were accepted as significant 
different.      
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Chapter 4. Results 
 
4.1 Oxidative stress levels in brain of PINK1 knockout mice compared to 
age-matched control 
 PINK1-deficient brain has elevated oxidative stress. Protein carbonyls, 
HNE, 3NT, as the widespread indicators of oxidative stress, were used to index 
the effects of PINK1 knockout in brain. 
 
  
31 
 
4.2 Protein carbonyl levels increase in PINK1 knockout mice compared 
to age-matched control 
 Figure 4.1 shows protein carbonyl levels in the brains of PINK1 knockout 
mice and age-matched control mice. The level of protein carbonyls was found to 
be significantly increased in PINK1 knockout mice compared to age-matched 
controls (P<0.002). This increase in protein carbonyl is approximately 13% higher 
than control. 
 
 
Figure 4.1 Protein carbonyl level in PINK1 knockout mice compared to age-
matched control mice.  
PC level was measured using slot blot. Data are shown as % control. All the 
values are expressed as mean ± SEM, wild type n=6, PINK1 knockout n=6. *P < 
0.002. 
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4.3 HNE-bound protein levels increase in brain of PINK1 knockout mice 
compared to age-matched control 
 Figure 4.2 shows HNE-modified protein levels in the brains of PINK1 
knockout mice and age-matched control mice. The level of HNE-bound protein 
was found to be significantly increased in PINK1 knockout mice compared to 
age-matched controls (P<0.02). This increase in protein-bound HNE is 
approximately 14% higher than control.  
 
 
Figure 4.2 HNE-bound protein level in PINK1 knockout mice compared to age-
matched control mice.  
HNE level was measured using western blot technique. Tubulin was used as a 
loading control to normalize the intensity of HNE-bound protein bands. Data are 
shown as % control. All the values are expressed as mean ± SEM, wild type n=6, 
PINK1 knockout n=6. *P < 0.02. 
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4.4 Protein-3NT levels are unchanged in brain of PINK1 knockout mice 
compared to age-matched control 
 Figure 4.3 shows 3-Nitrotyrosine levels in the brains of PINK1 knockout 
mice and age-matched control mice. The level of 3-NT was not found to be 
significantly changed in PINK1 knockout mice compared to age-matched controls.  
 
 
Figure 4.3  3-NT resident protein level in PINK1 knockout mice compared to age-
matched control mice.  
3-NT level was measured using slot blot. Data are shown as % control. All the 
values are expressed as mean ± SEM, wild type n=6, PINK1 knockout n=6. No 
significant differences were observed for PINK1 knockout mice. 
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4.5 HO-1/BVR system levels in PINK1 knockout mice compared to age-
matched control 
We previously have shown that PINK1 knockout causes increased 
oxidative stress in brain. However, HO-1/BVR is an antioxidant system defense 
against ROS or RNS stress. Therefore, we wanted to determine the effect of 
oxidative stress on HO-1/BVR system. We measured the levels of HO-1 and 
BVR in the brains of wild type mice and PINK1 knockout mice, respectively. 
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4.6 HO-1 levels decrease slightly, but not statistically significant in brain 
of PINK1 knockout mice compared to age-matched control 
  Figure 4.4 shows heme oxygenase-1 levels in the brains of PINK1 
knockout mice and age-matched control mice. The level of HO-1 was not found 
to be significantly changed in brain of PINK1 knockout mice compared to age-
matched controls.  
 
 
                  HO-1        
                  Tubulin     
                                   WT1    KO1    WT2    KO2 
Figure 4.4 Heme Oxygenase-1 level in PINK1 knockout mice compared to age-
matched control mice.  
HO-1 level was measured using western blot technique. Tubulin was used as a 
loading control to normalize the intensity of HO-1 bands. Data are shown as % 
control. All the values are expressed as mean ± SEM, wild type n=6, PINK1 
knockout n=6. No significant differences were observed for PINK1 knockout mice. 
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4.7 BVR levels increase in brain of PINK1 knockout mice compared to 
age-matched control 
 Figure 4.5 shows biliverdin reductase levels in the brains of PINK1 
knockout mice and age-matched control mice. The level of BVR was found to be 
significantly increased in PINK1 knockout mice compared to age-matched 
controls (P<0.03). This increase in BVR is approximately 14% higher than control.  
 
 
                  BVR         
                 Tubulin      
                                       WT1   KO1   WT2   KO2 
Figure 4.5 Biliverdin Reductase level in PINK1 knockout mice compared to age-
matched control mice.  
BVR level was measured using western blot technique. Tubulin was used as a 
loading control to normalize the intensity of BVR bands. Data are shown as % 
control. All the values are expressed as mean ± SEM, wild type n=6, PINK1 
knockout n=6 Data are shown as % control. *P < 0.03. 
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4.8 Levels of BVR oxidative post-translational modification in brain of 
PINK1 knockout mice compared to age-matched control 
 In PINK1 knockout mice, heme oxygenase-1 levels did not change while 
biliverdin reductase levels increased indicating that BVR plays a more important 
role in response to oxidative stress. Therefore, we determined levels of BVR 
oxidative post-translational modification.  
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4.9 Protein carbonyl levels on BVR levels do not change in brain of 
PINK1 knockout mice compared to age-matched control 
 Figure 4.6 shows protein carbonyl levels of biliverdin reductase in the 
brains of PINK1 knockout mice and age-matched control mice. No apparent 
differences in the intensity of PC of BVR was found between PINK1 knockout 
mice and age-matched controls. 
 
 
                  CO-BVR       
                        BVR      
                                        WT1   KO1   WT2   KO2 
Figure 4.6  Protein carbonyl of BVR level in PINK1 knockout mice compared to 
age-matched control mice.  
PC level was measured using immunoprecipitation. BVR was used as a loading 
control to normalize the intensity of protein carbonyl on BVR bands.  Data are 
shown as % control. All the values are expressed as mean ± SEM, wild type n=6, 
PINK1 knockout n=6. No significant differences were observed for PINK1 
knockout mice. 
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4.10 Levels of HNE-bound BVR do not change in brain of PINK1 knockout 
mice compared to age-matched control 
 Figure 4.7 illustrates HNE-bound biliverdin reductase levels in the brains 
of PINK1 knockout mice and age-matched control mice. No apparent differences 
in the intensity of HNE-bound BVR was found between PINK1 knockout mice 
and age-matched controls. 
 
 
             HNE-BVR           
                     BVR            
                                        WT1   KO1   WT2   KO2 
Figure 4.7 HNE-bound BVR level in PINK1 knockout mice compared to age-
matched control mice.  
HNE level was measured employing immunoprecipitation. BVR was used as a 
loading control to normalize the intensity of HNE-bound BVR bands. Data are 
shown as % control. All the values are expressed as mean ± SEM, wild type n=6, 
PINK1 knockout n=6. No significant differences were observed for PINK1 
knockout mice. 
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4.11 Levels of 3NT on BVR do not change in brain of PINK1 knockout 
mice compared to age-matched control 
 Figure 4.8 shows 3-NT of biliverdin reductase levels in the brains of PINK1 
knockout mice and age-matched control mice. 3-NT of BVR did not show any 
change between PINK1 knockout mice and age-matched controls. 
 
 
                3NT-BVR        
                       BVR          
                                         WT1  KO1  WT2   KO2 
Figure 4.8 3NT-bound BVR level in PINK1 knockout mice compared to age-
matched control mice.  
3-NT level was measured employing immunoprecipitation. BVR was used as a 
loading control to normalize the intensity of 3NT on BVR bands. Data are shown 
as % control. All the values are expressed as mean ± SEM, wild type n=3, PINK1 
knockout n=3. No significant differences were observed for PINK1 knockout mice. 
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4.12 BVR phosphorylation post-translational modification levels in PINK1 
knockout mice compared to age-matched control 
 Biliverdin reductase is an antioxidant enzyme as well as a serine/threonine 
kinase. As Section 4.3 shows, oxidative post-translational modification of BVR 
was inhibited, conceivably by its antioxidant function, i.e. by production of 
bilirubin. In this section, we wanted to investigate whether the increase level of 
BVR induce the change of BVR phosphorylation post-translational modification 
levels. 
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4.13 BVR phosphoserine levels significantly increase in brain of PINK1 
knockout mice compared to age-matched control 
 Figure 4.9 shows biliverdin reductase phosphoserine levels in the brains 
of PINK1 knockout mice and age-matched control mice. The level of BVR 
phosphoserine was found to be significantly increased in PINK1 knockout mice 
compared to age-matched controls (P<0.03). This increase in BVR 
phosphoserine is approximately 90% higher than control.  
 
 
   Ser-BVR       
                    BVR        
     WT1    KO1    WT2    KO2 
Figure 4.9  BVR phosphoserine level in PINK1 knockout mice compared to age-
matched control mice.  
BVR phosphoserine level was measured using immunoprecipitation. BVR was 
used as a loading control to normalize the intensity of BVR phosphoserine bands. 
Data are shown as % control. All the values are expressed as mean ± SEM, wild 
type n=3, PINK1 knockout n=3. *P < 0.005. 
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4.14 BVR phosphothreonine levels increase in brain of PINK1 knockout 
mice compared to age-matched control 
Figure 4.10 shows biliverdin reductase phosphothreonine levels in the 
brains of PINK1 knockout mice and age-matched control mice. The level of BVR 
phosphothreonine was found to be significantly increased in PINK1 knockout 
mice compared to age-matched controls (P<0.05). This increase in BVR 
phosphothreonine is approximately 31% higher than control.  
 
 
                Thr-BVR         
                     BVR          
                                          WT1   KO1   WT2    KO2 
Figure 4.10 BVR phosphothreonine level in PINK1 knockout mice compared to 
age-matched control mice.  
BVR phosphothreonine level was measured using immunoprecipitation. BVR 
was used as a loading control to normalize the intensity of BVR 
phosphothreonine bands. Data are shown as % control. All the values are 
expressed as mean ± SEM, wild type n=3, PINK1 knockout n=3. *P < 0.05. 
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Chapter 5. Discussion 
 PINK1 is a gene that is linked to autosomal recessive familial Parkinson’s 
disease (Varcin, Bentea et al. 2012). PINK1 functions as a serine/threonine 
kinase as well as a protector of mitochondrial function. Mutation of the PINK1 
gene contributes to the loss of mitochondrial protection against oxidative stress 
(Moore, West et al. 2005). In fact, mitochondrial dysfunction plays a central role 
in the pathogenesis of PD (Yao, Gandhi et al. 2011). Because of the function of 
PINK1 protein, we expected two aspects of differences, oxidation and 
phosphorylation, resulting from the loss of PINK1. This thesis research 
investigated the effect of the defect of PINK1 on oxidative stress and heme 
oxygenase-1/biliverdin reductase post-translational modifications. PINK1 
knockout mouse is a genetic model of PD that used to study oxidative stress in 
this thesis. 
The dysfunction of mitochondria leads to ROS and oxidative stress. In PD, 
oxidative stress contributes to the neurodegeneration (Andersen 2004). PINK1, 
as a PD-related gene, may cause oxidative stress as well if it is mutated. 
Oxidative stress contributes to the production of protein carbonyls, HNE, and 3-
NT. In this study, significant increased levels of protein carbonyls and HNE were 
observed in PINK1 knockout mice compared to control mice. These results are 
consistent with our hypothesis that oxidative stress is elevated in the brain of 
PINK1 knockout mice. In contrast, however, previous studies reported 
unchanged levels of protein carbonyls and HNE-bound proteins in different parts 
of the brain of PINK1 knockout mice at 24 months (Gautier, Kitada et al. 2008). It 
is possible that the time for sample homogenization in this work differs from the 
one reported in the literature. Longer preparation time would increase free 
radicals in the samples. Additionally, the level of 3-NT bound protein given by 
present data did not show any apparent change.   
In order to prevent cellular impairment, antioxidant systems have been 
considered to respond to the up-regulated oxidative stress. The heme 
oxygenase-1/Biliverdin reductase system is such an example. Biliverdin 
45 
 
reductase reduces biliverdin, the product of heme degraded by heme oxygenase-
1, to the antioxidant bilirubin. To determine if the increase in oxidative stress 
levels observed in PINK1 knockout mice were related to the HO-1/BVR system, 
HO-1 and BVR protein expression were measured, respectively. It is unclear how 
the HO-1/BVR system functions in Parkinson’s disease to date, even though it 
has been studied well in Alzheimer disease (Barone, Di Domenico et al. 2011,  
Barone, Di Domenico et al. 2011, Barone, Di Domenico et al. 2014). The current 
results, for the first time, report that the level of BVR was significantly increased 
in PINK1 knockout mice. The increased of BVR rather than HO-1 indicates that 
the terminal product of this system, bilirubin, becomes more efficient to scavenge 
ROS. Recent studies showed the conversion from heme to biliverdin by heme 
oxygenase-1 is not always neuro-protective. A product of this reaction, iron (II), 
can cause free radicals by Fenton chemistry and subsequently initiate oxidative 
stress (Gutteridge, Maidt et al. 1990). Moreover, HO-1 level in the substantia 
nigra neurons of PD and control cases are similar (Schipper 2000). PINK1 
knockout, as a model of PD, presents similar results as in our study. However, a 
significant increase in BVR protein level promotes its ability to keep cellular 
homeostasis.   
Furthermore, we chose to investigate the post-translational modifications 
of BVR for the following experiments because of its elevated ability to combat 
oxidative stress as shown in this thesis research. Previous work leads to the 
hypothesis that oxidative modification of BVR may decrease. The current results 
obtained from immunoprecipitation technique showed similar levels of protein 
carbonyls, HNE, and 3-NT of BVR in both PINK1 knockout mice and controls 
mice. These results are in accordance with the hypothesis that high levels of 
BVR are efficient to keep oxidative modification of BVR back to normal level. 
Another novel finding of this thesis research is the change of 
phosphorylation modification of BVR in PINK1 knockout mice. Since PINK1 
serves as a serine/threonine kinase, phosphorylation of BVR may be changed if 
PINK1 gene is deficient. On the other hand, BVR is capable of 
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autophosphorylation, and phosphorylation is important for its activation (Salim, 
Brown-Kipphut et al. 2001). Serine and threonine are the targets for BVR 
phosphorylation. The data presented in this research demonstrated significant 
increased BVR phosphoserine and phosphothreonine in PINK1 knockout mice 
brain with respect to controls. These results provided another reasonable 
explanation for the previous work showing up-regulation of BVR activated by the 
increased phosphorylation. Based on Fabio Di Domenico’s work (Di Domenico, 
Perluigi et al. 2013), we may speculate that activated BVR together with 
increased production of antioxidant is able to keep nitric oxide levels under 
control. Therefore, even elevated NOS levels result from PINK1 knockout will not 
cause higher nitrosative stress levels. However, further studies are needed to 
confirm this hypothesis. Interestingly, these results, in contrast, show increased 
BVR phosphorylation together with deficient PINK1 kinase. A possible 
interpretation is that PINK1 protein, as a kinase, does not regulate BVR 
phosphorylation directly. This notion will be the subject of future studies from our 
laboratory. 
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Chapter 6. Conclusion and Future Studies 
 In conclusion, the work presented in this thesis showed the presence of 
oxidative stress along with the alternation of BVR post-translational modification 
in the brain of PINK1 knockout mice. Specifically, we examined levels of protein 
carbonyls, HNE-bound proteins, and nitrated proteins. The results established a 
relationship between oxidative stress and the mice brain with PINK1 
abnormalities. The notion that antioxidant system makes a response to oxidative 
stress has been demonstrated by the up-regulated levels of BVR. With regard to 
BVR post-translational modification, we observed an unchanged level of 
oxidative translational modification along with significant increase in Ser-residue 
and Thr-residue phosphorylation, which demonstrated antioxidant and 
autophosphorylation abilities of BVR in the brain of PINK1 knockout mice. We 
first reported the characterization of HO-1/BVR system in PINK1 knockout mice 
which has been only studied with respect to Alzheimer disease to date, providing 
a new perspective of treatment of Parkinson’s disease.  
 Based on the results in this thesis, we may be concern about the following 
experiments for future studies: 
1. BVR has been found involved in insulin signaling pathway. It is a substrate 
for insulin receptor as well as a kinase for insulin receptor kinase, 
regulating MAPK and PI3K cascades. The findings of up-regulated levels 
of BVR and alternation of phosphorylation of BVR in PINK1 knockout mice 
may indicate its possible role in insulin receptor system. Therefore, it will 
be meaningful to investigate whether cell signal function of BVR changed 
in PINK1 deficiency cells.   
2. Determine the level of nitric oxide synthase, which verifies the speculation 
that activated BVR keeps protein 3-NT levels in normal. 
3. Determine whether PINK1 protein, as a kinase, regulates BVR 
phosphorylation directly or not.  
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Appendix: Data to Supplement Figures 
 
Figure 4.1 Protein carbonyl levels 
 Wildtype Knockout 
 6823135 8908625 
 6275115 8637365 
 7829250 7157315 
 6759170 7260220 
 7151485 8443655 
 8013335 8376885 
Average 7141915 8130678 
   
%Control 95.54 124.74 
 87.86 120.94 
 109.62 100.22 
 94.64 101.66 
 100.13 118.23 
 112.20 117.29 
Average 100.00 113.84 
Std Dev 8.54 9.44 
SEM 3.49 3.85 
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Figure 4.2 Protein-bound HNE levels  
 
Wildtype Knockout 
HNE 34907999 40400364 
 
37492364 39958416 
 
35837672 32791518 
 
34825302 37018140 
 
34725652 36654780 
 
37958856 42221274 
Tubulin 46031927 41935731 
 
40305920 35982408 
 
36999128 34531368 
 
40106885 38904120 
 
39598381 37568073 
 
44750475 39060360 
HNE/Tubulin 0.758 0.963 
 
0.93 1.11 
 
0.969 0.95 
 
0.868 0.952 
 
0.877 0.976 
 
0.848 1.081 
Average 0.875 1.005 
   
%Control 86.66 110.09 
 
106.3 126.9 
 
110.68 108.51 
 
99.22 108.73 
 
100.21 111.49 
 
96.93 123.52 
Average 100 114.87 
Std Dev 8.27 8.15 
SEM 3.38 3.33 
 
  
   
   
   
   
   
   
   
   
   
   
   
50 
 
Figure 4.3 Protein-3NT levels 
 
Wildtype Knockout 
3-NT 45019512 46365264 
 
51666336 51932592 
 
52212384 43072632 
 
50711544 45826776 
 
48658968 46948320 
 
50685984 44181144 
Tubulin 39980162 36624280 
 
35791371 39364325 
 
36876224 35965853 
 
39662546 40425693 
 
43543962 39682489 
 
41674556 43997800 
3-NT/Tubulin 1.13 1.27 
 
1.44 1.32 
 
1.42 1.2 
 
1.28 1.13 
 
1.12 1.18 
 
1.22 1 
Average 1.27 1.18 
   
%Control 88.92 99.97 
 
114 104.18 
 
111.81 94.58 
 
100.97 89.52 
 
88.25 93.43 
 
96.05 79.3 
Average 100 93.5 
Std Dev 11.07 8.66 
SEM 4.52 3.53 
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Figure 4.4 Heme Oxygenase-1 levels 
 
Wildtype Knockout 
HO-1 1139502 1021488 
 
1351896 1002456 
 
1119924 1119300 
 
1309776 1273584 
 
1327404 1217424 
 
1110330 994578 
Tubulin 53901542 46671750 
 
41292636 44621192 
 
41881779 41300625 
 
44186552 45388112 
 
50727465 49461742 
 
48209025 51953671 
HO-
1/Tubulin 
2.11E-02 2.19E-02 
 
3.27E-02 2.25E-02 
 
2.67E-02 2.71E-02 
 
2.96E-02 2.81E-02 
 
2.62E-02 2.46E-02 
 
2.30E-02 1.91E-02 
Average 2.66E-02 2.39E-02 
   
%Control 79.54 82.35 
 
123.19 84.53 
 
100.61 101.97 
 
111.53 105.58 
 
98.46 92.61 
 
86.66 72.03 
Average 100 89.85 
Std Dev 15.94 12.68 
SEM 6.51 5.18 
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Figure 4.5 Biliverdin Reductase levels 
 
Wildtype Knockout 
BVR 520191 672543 
 
610650 709389 
 
672543 630936 
 
637146 650739 
 
583326 718428 
 
650118 
 
Tubulin 47594448 43322240 
 
42192780 43832000 
 
42309280 42683120 
 
49431120 39930480 
 
44433732 43680000 
 
41476400 
 
BVR/Tubulin 1.09E-02 1.55E-02 
 
1.45E-02 1.62E-02 
 
1.59E-02 1.48E-02 
 
1.29E-02 1.63E-02 
 
1.31E-02 1.64E-02 
 
1.57E-02 
 
Average 1.38E-02 1.58E-02 
   
%Control 79.02 112.24 
 
104.64 117.01 
 
114.92 106.87 
 
93.19 117.82 
 
94.91 118.91 
 
113.32 
 
Average 100 114.57 
Std Dev 13.67 5 
SEM 5.58 2.04 
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Figure 4.6 Protein carbonyl on BVR levels 
  
 
Wildtype Knockout 
PC 16029778 21038308 
 
12708059 14937260 
 
15736610 20837193 
 
18416659 18730121 
 
13408129 17738197 
 
14260185 20781713 
BVR 401147 1207716 
 
387543 656469 
 
521683 528238 
 
750063 397195 
 
371792 715616 
 
370215 698915 
PC/BVR 39.96 17.42 
 
32.79 22.75 
 
30.17 39.45 
 
24.55 47.16 
 
36.06 24.79 
 
38.52 29.73 
Average 33.68 30.22 
   
%Control 118.66 51.73 
 
97.38 67.57 
 
89.58 117.14 
 
72.91 140.03 
 
107.09 73.61 
 
114.38 88.3 
Average 100 89.73 
Std Dev 17.06 33.1 
SEM 6.96 13.51 
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Figure 4.7 Levels HNE-bound BVR 
 
Wildtype Knockout 
HNE 14336397 17455541 
 
16564065 22703803 
 
17595701 16705104 
 
15458559 13785034 
 
12427050 14810996 
 
15956206 17532588 
BVR 10769700 15236925 
 
14331360 20543925 
 
17611853 18666900 
 
12054189 13601967 
 
8988501 8221908 
 
12228438 11267703 
HNE/BVR 1.33 1.15 
 
1.16 1.11 
 
1 0.89 
 
1.28 1.01 
 
1.38 1.16 
 
1.3 1.56 
Average 1.24 1.15 
   
%Control 107.12 92.19 
 
93.01 88.93 
 
80.4 72.02 
 
103.2 81.56 
 
111.26 93.06 
 
105.01 125.22 
Average 100 92.16 
Std Dev 11.37 18.01 
SEM 4.64 7.35 
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Figure 4.8 Levels of 3NT on BVR 
 
Wildtype Knockout 
3NT 3018525 4353600 
 
4056150 5238450 
 
5465925 5299520 
BVR 10769700 15236925 
 
14331360 20543925 
 
17611853 18666900 
3NT/BVR 2.80E-01 2.86E-01 
 
2.83E-01 2.55E-01 
 
3.10E-01 2.84E-01 
Average 2.91E-01 2.75E-01 
   
%Control 96.24 98.11 
 
97.19 87.56 
 
106.57 97.49 
Average 100 94.39 
Std Dev 5.71 5.92 
SEM 3.3 3.42 
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Figure 4.9 BVR phosphoserine levels 
 
Wildtype Knockout 
Ser 20574264 13354948 
 
22601488 17261880 
 
20813664 11428044 
BVR 12768528 3753604 
 
11819556 6156662 
 
10791844 3550182 
Ser/BVR 1.61 3.56 
 
1.91 2.8 
 
1.93 3.22 
Average 1.82 3.19 
   
%Control 88.66 195.77 
 
105.22 154.27 
 
106.12 177.12 
Average 100 175.72 
Std Dev 9.83 20.78 
SEM 5.68 12 
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Figure 4.10 BVR phosphothreonine levels  
 
Wildtype Knockout 
Thr 19667625 24868690 
 
21120890 22653820 
 
23647960 23021740 
BVR 10683512 11333476 
 
13345992 10113440 
 
17053968 12339876 
Thr/BVR 1.84 2.19 
 
1.58 2.24 
 
1.39 1.87 
Average 1.6 2.1 
   
%Control 114.82 136.85 
 
98.7 139.7 
 
86.48 116.36 
Average 100 130.97 
Std Dev 14.21 12.74 
SEM 8.2 7.35 
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